Intrinsic Imaging Awarded Clinical Study for Novel Neurointerventional Medical Device

Boston, MA / San Antonio, TX — February 12, 2014 — Intrinsic Imaging, an FDA audited, ISO 9001 and ISO 13485 certified medical imaging core lab specializing in providing imaging core lab services for clinical trials, announced today that it has been awarded a clinical study for a novel neurointerventional medical device.

Throughout this trial, Intrinsic Imaging will provide comprehensive imaging core lab services including specialized radiologic review by its team of board-certified interventional neuroradiologists.

Neurointerventional medical devices enable sophisticated endovascular procedures within the vessels of the brain to treat stroke and other neurological disorders. This class of medical devices encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), stenting systems (carotid and intracranial stents including embolic protection systems), aneurysm coiling devices (platinum coils and liquid embolic agents) and a myriad of support devices (microcatheters and microguidewires).

"The increasing prevalence of vascular disorders of the brain and spine has resulted in the development of many neurointerventional devices requiring detailed imaging evaluation," said Todd A. Joron, BSc. MBA, President & COO, Intrinsic Imaging. "Our team of board-certified, fellowship-trained interventional neuroradiologists have extensive training and expertise in the utilization and evaluation of neurointerventional devices."